代谢性炎症综合征与日常生活方式相关性的研究进展
Research Progress on the Correlation between Metabolic Inflammatory Syndrome and Daily Lifestyle
DOI: 10.12677/ACM.2023.13102233, PDF,   
作者: 谢伟萍：青海大学研究生院，青海 西宁；王卓亚*：青海大学附属医院老年科，青海 西宁
关键词: 代谢性炎症综合征；地中海饮食；体力活动水平；睡眠卫生；Metabolic Inflammatory Syndrome； Mediterranean Diet； Physical Activity； Good Sleep Hygiene
摘要: 代谢性炎症综合征是一组慢性非传染性疾病，大量研究表明，日常生活方式与代谢性炎症综合征的防治关联密切。相较于药物干预，依靠日常生活方式，如地中海饮食、良好的睡眠卫生、高水平日常体力活动量，对减少代谢性炎症综合征引起的疾病风险更为经济便捷。本文回顾代谢性炎症综合征的起源及其发病机制，通过对日常生活方式与代谢性炎症综合征的相关性进行综述，重点关注日常生活方式对改善代谢性炎症综合征病理结果的影响，旨在为代谢性炎症综合征的早期生活方式干预提供理论依据。
Abstract: Metabolic inflammatory syndrome (MIS) is a group of chronic non-communicable diseases, and nu-merous studies have shown that daily lifestyle is strongly associated with the prevention and treatment of MIS. Relying on daily lifestyle, such as the Mediterranean diet, good sleep hygiene, and high level of daily physical activity, is more cost-effective and convenient than pharmacological in-terventions to reduce the risk of diseases caused by metabolic inflammatory syndrome. This article reviews the origin of the metabolic inflammatory syndrome and its pathogenesis, and aims to pro-vide a theoretical basis for early lifestyle intervention in metabolic inflammatory syndrome by re-viewing the correlation between daily lifestyle and metabolic inflammatory syndrome, focusing on the impact of daily lifestyle on improving the pathology outcome of the metabolic inflammatory syndrome.
文章引用：谢伟萍, 王卓亚. 代谢性炎症综合征与日常生活方式相关性的研究进展[J]. 临床医学进展, 2023, 13(10): 15977-15985. https://doi.org/10.12677/ACM.2023.13102233

参考文献

[1] 黎汝楣, 胡仁明. 代谢性炎症综合征发病机制的研究进展[J]. 复旦学报(医学版), 2017, 44(3): 380-384.
[2] 胡仁明. 代谢性炎症综合征的概念及临床意义[J]. 临床荟萃, 2016, 31(9): 960-963.
[3] 胡仁明, 谢颖, 鹿斌, 等. 2型糖尿病患者高发“代谢性炎症综合征” [J]. 中华内分泌代谢杂志, 2016, 23(1): 27-32.
[4] Fahed, G., Aoun, L., Bou Zerdan, M., et al. (2022) Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences, 23, Article No. 786. [Google Scholar] [CrossRef] [PubMed]
[5] Myers, J., Kokki-nos, P. and Nyelin, E. (2019) Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome. Nutrients, 11, Article No. 1652. [Google Scholar] [CrossRef] [PubMed]
[6] Fathi Dizaji, B. (2018) The Investigations of Genetic Determinants of the Metabolic Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12, 783-789. [Google Scholar] [CrossRef] [PubMed]
[7] Riley, L., Guthold, R., Cowan, M., et al. (2016) The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. American Journal of Public Health, 106, 74-78. [Google Scholar] [CrossRef] 
[8] Reaven, G.M. (1988) Role of Insulin Resistance in Human Dis-ease. Diabetes, 37, 1595-1607. [Google Scholar] [CrossRef] [PubMed]
[9] Alberti, K.G.M.M., Zimmet, P.Z. and WHO Consultation (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553. [Google Scholar] [CrossRef] 
[10] Rochlani, Y., Pothineni, N.V., Kovelamudi, S., et al. (2017) Metabolic Syndrome: Pathophysiology, Management, and Modulation by Natural Compounds. Therapeutic Advances in Cardiovascular Disease, 11, 215-225. [Google Scholar] [CrossRef] [PubMed]
[11] Hsu, C.-N., Hou, C.-Y., Hsu, W.-H., et al. (2021) Early-Life Or-igins of Metabolic Syndrome: Mechanisms and Preventive Aspects. International Journal of Molecular Sciences, 22, Ar-ticle No. 11872. [Google Scholar] [CrossRef] [PubMed]
[12] Saklayen, M.G. (2018) The Global Epidemic of the Metabolic Syn-drome. Current Hypertension Reports, 20, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[13] Hsu, C.-N. and Tain, Y.-L. (2021) Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. International Journal of Molecular Sciences, 22, Article No. 2298. [Google Scholar] [CrossRef] [PubMed]
[14] Jašarević, E. and Bale, T.L. (2019) Prenatal and Postnatal Contributions of the Maternal Microbiome on Offspring Programming. Frontiers in Neuroendocrinology, 55, Article ID: 100797. [Google Scholar] [CrossRef] [PubMed]
[15] Hsu, C.-N., Hou, C.-Y., Hsu, W.-H., et al. (2021) Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy. Nutrients, 13, Article No. 2290. [Google Scholar] [CrossRef] [PubMed]
[16] Cioffi, F., Giacco, A., Petito, G., et al. (2022) Altered Mitochon-drial Quality Control in Rats with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Induced by High-Fat Feeding. Genes, 13, Article No. 315. [Google Scholar] [CrossRef] [PubMed]
[17] Silvestri, E., Senese, R., Cioffi, F., et al. (2019) 3,5-Diiodo-L-Thyronine Exerts Metabolically Favorable Effects on Visceral Adipose Tissue of Rats Receiving a High-Fat Diet. Nutrients, 11, Article No. 278. [Google Scholar] [CrossRef] [PubMed]
[18] Pant, S., Deshmukh, A., GuruMurthy, G.S., et al. (2014) Inflammation and Atherosclerosis—Revisited. Journal of Cardiovascular Pharmacology and Therapeutics, 19, 170-178. [Google Scholar] [CrossRef] [PubMed]
[19] Diemieszczyk, I., Głuszyńska, P., Wojciak, P.A., et al. (2021) Metabolic Syndrome. Etiology and Pathogenesis. Wiadomosci Lekarskie (Warsaw, Poland: 1960), 74, 2510-2515. [Google Scholar] [CrossRef] 
[20] Nolan, C.J. and Prentki, M. (2019) Insulin Resistance and Insulin Hypersecretion in the Metabolic Syndrome and Type 2 Diabetes: Time for a Conceptual Framework Shift. Diabetes and Vascular Disease Research, 16, 118-127. [Google Scholar] [CrossRef] [PubMed]
[21] Motamed, N., Miresmail, S.J.H., Rabiee, B., et al. (2016) Optimal Cutoff Points for HOMA-IR and QUICKI in the Diagnosis of Metabolic Syndrome and Non-Alcoholic Fatty Liver Dis-ease: A Population Based Study. Journal of Diabetes and Its Complications, 30, 269-274. [Google Scholar] [CrossRef] [PubMed]
[22] Obradovic, M., Sudar-Milovanovic, E., Soskic, S., et al. (2021) Leptin and Obesity: Role and Clinical Implication. Frontiers in Endocrinology, 12, Article ID: 585887. [Google Scholar] [CrossRef] [PubMed]
[23] Shafer-Eggleton, J., Adams-Huet, B. and Jialal, I. (2020) Chemerin Ratios to HDL-Cholesterol and Adiponectin as Biomarkers of Metabolic Syndrome. Endocrine Research, 45, 241-245. [Google Scholar] [CrossRef] [PubMed]
[24] Himes, R.W. and Smith, C.W. (2010) Tlr2 Is Critical for Di-et-Induced Metabolic Syndrome in a Murine Model. The FASEB Journal, 24, 731-739. [Google Scholar] [CrossRef] [PubMed]
[25] Thakkinstian, A., Chailurkit, L., Warodomwichit, D., et al. (2014) Causal Relationship between Body Mass Index and Fetuin-A Level in the Asian Population: A Bidirectional Mendelian Ran-domization Study. Clinical Endocrinology, 81, 197-203. [Google Scholar] [CrossRef] [PubMed]
[26] Pérez-Sotelo, D., Roca-Rivada, A., Larrosa-García, M., et al. (2017) Visceral and Subcutaneous Adipose Tissue Express and Secrete Functional Alpha-2-HS-Glycoprotein (Fetuin a) Especially in Obesity. Endocrine, 55, 435-446. [Google Scholar] [CrossRef] [PubMed]
[27] Pan, X., Wen, S.W., Bestman, P.L., et al. (2020) Fetuin-A in Metabolic Syndrome: A Systematic Review and Meta-Analysis. PLOS ONE, 15, e0229776. [Google Scholar] [CrossRef] [PubMed]
[28] Masschelin, P.M., Cox, A.R., Chernis, N., et al. (2020) The Impact of Oxidative Stress on Adipose Tissue Energy Balance. Frontiers in Physiology, 10, Article No. 1638. [Google Scholar] [CrossRef] [PubMed]
[29] Bhatti, J.S., et al. (2017) Mitochondrial Dysfunction and Oxidative Stress in Metabolic Disorders—A Step towards Mitochondria Based Therapeutic Strategies. Biochimica et Biophysica Acta Molecular Basis of Disease, 1863, 1066- 1077.
[30] Burkart, A.M., Tan, K., Warren, L., et al. (2016) Insulin Re-sistance in Human iPS Cells Reduces Mitochondrial Size and Function. Scientific Reports, 6, Article No. 22788. [Google Scholar] [CrossRef] [PubMed]
[31] Ramzan, F., D’Souza, R.F., Durainayagam, B.R., et al. (2020) Circulatory miRNA Biomarkers of Metabolic Syndrome. Acta Diabetologica, 57, 203-214. [Google Scholar] [CrossRef] [PubMed]
[32] De Jesus, D.F., Orime, K., Kaminska, D., et al. (2020) Parental Metabolic Syndrome Epigenetically Reprograms Offspring Hepatic Lipid Metabolism in Mice. Journal of Clinical Inves-tigation, 130, 2391-2407. [Google Scholar] [CrossRef] 
[33] Silvestri, E. and Giacco, A. (2022) Diet, Exercise, and the Metabolic Syn-drome: Enrollment of the Mitochondrial Machinery. Nutrients, 14, Article No. 4519. [Google Scholar] [CrossRef] [PubMed]
[34] Chauhan, H., Belski, R., Bryant, E., et al. (2022) Dietary Assessment Tools and Metabolic Syndrome: Is It Time to Change the Focus? Nutrients, 14, Article No. 1557. [Google Scholar] [CrossRef] [PubMed]
[35] Martínez-Espinosa, P.G., et al. (2019) Practical Guidance for Interven-tions in Adults with Metabolic Syndrome: Diet and Exercise vs. Changes in Body Composition. International Journal of Environmental Research and Public Health, 16, Article No. 3481. [Google Scholar] [CrossRef] [PubMed]
[36] Banikazemi, Z., Haji, H.A., Mohammadi, M., et al. (2018) Diet and Cancer Prevention: Dietary Compounds, Dietary MicroRNAs, and Dietary Exosomes. Journal of Cellular Biochemistry, 119, 185-196. [Google Scholar] [CrossRef] [PubMed]
[37] Romero-Nava, R., García, N., Aguayo-Cerón, K.A., et al. (2021) Modifica-tions in GPR21 and GPR82 Genes Expression as a Consequence of Metabolic Syndrome Etiology. Journal of Receptors and Signal Transduction, 41, 38-44. [Google Scholar] [CrossRef] [PubMed]
[38] 鹿斌, 柏悦恬, 胡仁明. 强化慢性病防控, 促进全民健康——谈代谢性炎症综合征的综合防治[J]. 医学综述, 2020, 26(21): 4165-4167+4172.
[39] Gallardo-Alfaro, L., Bibiloni, M.D.M., Mascaró, C.M., et al. (2020) Leisure-Time Physical Activity, Sedentary Behaviour and Diet Quality are Associated with Metabolic Syndrome Severity: The PREDIMED-Plus Study. Nutrients, 12, Article No. 1013. [Google Scholar] [CrossRef] [PubMed]
[40] Bishehsari, F., Voigt, R.M. and Keshavarzian, A. (2020) Circadian Rhythms and the Gut Microbiota: From the Metabolic Syndrome to Cancer. Nature Reviews Endocrinology, 16, 731-739. [Google Scholar] [CrossRef] [PubMed]
[41] Chasens, E.R., Imes, C.C., Kariuki, J.K., et al. (2021) Sleep and Metabolic Syndrome. The Nursing Clinics of North America, 56, 203-217. [Google Scholar] [CrossRef] [PubMed]
[42] Anonymous (2020) Physical Exercise for Human Health. Springer, Singapore.
[43] Galmes-Panades, A.M., Varela-Mato, V., Konieczna, J., et al. (2019) Isotemporal Substitution of Inac-tive Time with Physical Activity and Time in Bed: Cross-Sectional Associations with Cardiometabolic Health in the PREDIMED-Plus Study. International Journal of Behavioral Nutrition and Physical Activity, 16, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[44] Wewege, M.A., Thom, J.M., Rye, K.-A., et al. (2018) Aerobic, Resistance or Combined Training: A Systematic Review and Meta-Analysis of Exercise to Reduce Cardiovascular Risk in Adults with Metabolic Syndrome. Atherosclerosis, 274, 162-171. [Google Scholar] [CrossRef] [PubMed]
[45] Mascaró, C.M., Bouzas, C., Montemayor, S., et al. (2022) Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome. Nutrients, 14, Article No. 1813. [Google Scholar] [CrossRef] [PubMed]
[46] Alizaei Yousefabadi, H., Niyazi, A., Alaee, S., et al. (2021) An-ti-Inflammatory Effects of Exercise on Metabolic Syndrome Patients: A Systematic Review and Meta-Analysis. Biologi-cal Research for Nursing, 23, 280-292. [Google Scholar] [CrossRef] [PubMed]

为你推荐